Ausgabe 6/2016
Inhalt (11 Artikel)
Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications
Alessandro Lupi, Alon Schaffer, Andrea Rognoni, Chiara Cavallino, Angelo S. Bongo, Bernardo Cortese, Allan S. Jaffe, Dominick J. Angiolillo, Italo Porto
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Prothrombotic Processes and Myocardial Infarction Risk
Csaba András Dézsi, Veronika Szentes
Statins in Primary Prevention: Uncertainties and Gaps in Randomized Trial Data
Ishak A. Mansi
Multivessel Revascularization Does Not Increase Contrast-Induced Acute Kidney Injury Incidence in Acute Myocardial Infarction: A Meta-Analysis
Bertrand N. Mukete, Russell A. Riehl, Alvaro Alonso, Rohan Samson, Abhishek Jaiswal, Thierry H. Le Jemtel
Assessment of the Cardiovascular Risk of Olmesartan Medoxomil-Based Treatment: Meta-Analysis of Individual Patient Data
Antonia C. Wang, Ulf Stellmacher, Jennifer Schumi, Nora Tu, Paul-Egbert Reimitz
Clinical Practice Guidelines for Hypertension: Evaluation of Quality Using the AGREE II Instrument
Xiaowei Zhang, Kun Zhao, Zhenggang Bai, Jing Yu, Feng Bai
Sebelipase Alfa: A Review in Lysosomal Acid Lipase Deficiency
James E. Frampton
Annual Congress of the European Society of Cardiology: August 27–31, 2016; Rome, Italy
Amitabh Prakash
Comment on: Ivabradine: A Review of Labeled and Off-Label Uses
Sébastien Champion
Erratum to: LDL-Cholesterol: Standards of Treatment 2016: A German Perspective
Winfried März, Hubert Scharnagl, Ioanna Gouni-Berthold, Günther Silbernagel, Alexander Dressel, Tanja B. Grammer, Ulf Landmesser, Hans Dieplinger, Eberhard Windler, Ulrich Laufs